Red Blood Cell-Derived Exosomal Oncogenic MicroRNA Promote Cancer Development and Progression

Jin Li,Pushpa Dhilipkannah,van Holden,Ashutosh Sachdeva,feng Jiang
DOI: https://doi.org/10.1101/2024.05.10.24307177
2024-05-10
Abstract:The role of red blood cells (RBCs) in tumorigenesis is poorly understood. We previously identified RBC-microRNAs with aberrations linked to lung cancer, including miR-93-5p. Here we find that miR-93-5p levels are elevated in RBC-derived exosomes among lung cancer patients and are associated with their shorter survivals. RBC-derived miR-93-5p transfers to cancer cells primarily through the exosomal pathway. The transferred RBC-miR-93-5p can target PTEN in cancer cells, and hence increase cell proliferation, invasion, and migration. RBC-derived miR-93-5p accelerates, whereas targeting miR-93-5p diminishes tumor growth in xenograft models. These findings reveal a novel biological function of RBCs in tumorigenesis, where they facilitate cancer progression by transferring the oncomiR via exosomes, thereby offering new diagnostic and treatment strategies for lung cancer.
What problem does this paper attempt to address?